Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022

SELL
$35.83 - $45.03 $172,306 - $216,549
-4,809 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$38.75 - $44.47 $161,471 - $185,306
-4,167 Reduced 46.42%
4,809 $205,000
Q2 2021

Aug 06, 2021

SELL
$39.42 - $48.08 $69,063 - $84,236
-1,752 Reduced 16.33%
8,976 $389,000
Q1 2021

May 10, 2021

SELL
$32.49 - $45.96 $106,274 - $150,335
-3,271 Reduced 23.37%
10,728 $438,000
Q4 2020

Feb 08, 2021

BUY
$32.59 - $45.26 $2,542 - $3,530
78 Added 0.56%
13,999 $634,000
Q3 2020

Nov 12, 2020

SELL
$32.56 - $38.57 $1,660 - $1,967
-51 Reduced 0.37%
13,921 $493,000
Q2 2020

Aug 07, 2020

BUY
$27.83 - $37.73 $3,979 - $5,395
143 Added 1.03%
13,972 $527,000
Q1 2020

May 12, 2020

SELL
$22.38 - $54.06 $27,079 - $65,412
-1,210 Reduced 8.05%
13,829 $400,000
Q4 2019

Feb 06, 2020

BUY
$51.85 - $73.36 $1,607 - $2,274
31 Added 0.21%
15,039 $780,000
Q3 2019

Nov 13, 2019

BUY
$40.05 - $57.47 $147,103 - $211,087
3,673 Added 32.4%
15,008 $824,000
Q2 2019

Aug 12, 2019

BUY
$30.3 - $41.14 $124,502 - $169,044
4,109 Added 56.86%
11,335 $460,000
Q1 2019

May 09, 2019

BUY
$29.37 - $40.49 $194,488 - $268,124
6,622 Added 1096.36%
7,226 $219,000
Q4 2018

Feb 11, 2019

BUY
$30.16 - $43.0 $1,960 - $2,795
65 Added 12.06%
604 $20,000
Q3 2018

Nov 13, 2018

BUY
$32.83 - $42.51 $7,386 - $9,564
225 Added 71.66%
539 $23,000
Q2 2018

Aug 09, 2018

BUY
$28.77 - $48.27 $4,775 - $8,012
166 Added 112.16%
314 $10,000
Q1 2018

May 14, 2018

SELL
$49.22 - $68.43 $295 - $410
-6 Reduced 3.9%
148 $7,000
Q4 2017

Feb 09, 2018

BUY
$52.14 - $59.94 $1,147 - $1,318
22 Added 16.67%
154 $8,000
Q3 2017

Nov 13, 2017

BUY
$51.16 - $58.21 $6,753 - $7,683
132
132 $8,000

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $240M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.